In this regard, liver disease is associated with a complex coagulopathy that is prone to thrombosis and bleeding [18], and thrombin testing was proposed to be used in conjunction with soluble thrombomodulin. This should alleviate the influence of protein anticoagulant action [18]. Here, THBD is linked to liver disorder.